[1]
Armstrong, A.W. et al. 2024. Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO). Acta Dermato-Venereologica. 104, (Sep. 2024), adv40556. DOI:https://doi.org/10.2340/actadv.v104.40556.